glp-1 drug market size Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 The Multi-Sector Impacts of GLP-1RA
Description
Quick Answer: GLP-1 receptor agonists produce modest cholesterol reductions (LDL-C by 2-10%, triglycerides by 10-20%) but should complement, not replace, statin therapy for lipid management
doi: 10.2337/diabetes.50.2007.s20
Available from: com/intelligence/pages/antiobesity-drug-market.html 8 Erman, M., 2023
A second paper, published in 1987, was a landmark: The tests showed that GLP-1 led to insulin secretion
[DOI] [PubMed] [Google Scholar] 45.FDA Approves Dulaglutide for Adults With T2D, Regardless of CVD
[DOI] [PMC free article] [PubMed] [Google Scholar] 775.Cannon B., Nedergaard J
